You Ask, Dan Fitzpatrick Answers

Fitzpatrick recently answered Stockpickr questions about Cell Therapeutics, shipping stocks and more.
Author:
Publish date:

Throughout the trading week on Stockpickr Answers, investing professionals answer questions posed by members of the Stockpickr community.

RealMoney's

Dan Fitzpatrick

answered questions recently.

On his latest TheStreet.com TV series "

3 Stocks I Saw on TV

," Fitzpatrick examined the charts of

Bank of America

(BAC) - Get Report

,

Dendreon

(DNDN)

and

Citigroup

(C) - Get Report

.

Here are some questions and comments from the Stockpickr community that Fitzpatrick responded to recently. You might have to scroll through to find his answers.

What do you think about the shipping stocks? I'm long DrysShips , Navios Maritime and Navistar .Click here for Fitzpatrick's response.

Any thoughts on ProLogis ? If we're in the early stages of a recovery as Cramer suggested, wouldn't warehouse real estate be a good place to be because there will be more demand for a place to store "stuff"? What say you on thetech side of things?Click here for Fitzpatrick's response.

How do you see Tecumseh Products ? It appears to be a rising star with Obama and green legislation. Click here for Fitzpatrick's response.

What are your thoughts on Ecolab ? Click here for Fitzpatrick's response.

Do you use the actual stock as your trading device, or do you also use optionsto employ your strategy? Click here for Fitzpatrick's response.

Do you see Cell Therapeutics getting to $20 to $25 in the future? Click here for Fitzpatrick's response.

Stockpickr is a wholly owned subsidiary of TheStreet.com.